These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38296897)

  • 41. Obinutuzumab as treatment for ANCA-associated vasculitis.
    Amudala NA; Boukhlal S; Sheridan B; Langford CA; Geara A; Merkel PA; Cornec D
    Rheumatology (Oxford); 2022 Aug; 61(9):3814-3817. PubMed ID: 34958343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe localised granulomatosis with polyangiitis (Wegener's granulomatosis) manifesting with extensive cranial nerve palsies and cranial diabetes insipidus: a case report and literature review.
    Peters JE; Gupta V; Saeed IT; Offiah C; Jawad ASM
    BMC Neurol; 2018 May; 18(1):59. PubMed ID: 29716529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting relapse in patients with Granulomatosis Polyangiitis: a single-center retrospective cohort study.
    Aydın Tufan M; Tekkarışmaz N; Yücel AE
    Turk J Med Sci; 2021 Aug; 51(4):1719-1726. PubMed ID: 33315347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients.
    Pérez-Jacoiste Asín MA; Charles P; Rothschild PR; Terrier B; Brézin A; Mouthon L; Guillevin L; Puéchal X
    Autoimmun Rev; 2019 May; 18(5):493-500. PubMed ID: 30844550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].
    de Groot K; Aries PM; Haubitz M; Hellmich B; Lamprecht P; Thiel J
    Dtsch Med Wochenschr; 2020 Jan; 145(1):40-46. PubMed ID: 31914468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
    Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
    Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged B cell depletion with rituximab is effective in treating refractory pulmonary granulomatous inflammation in granulomatosis with polyangiitis (GPA).
    Henderson SR; Copley SJ; Pusey CD; Ind PW; Salama AD
    Medicine (Baltimore); 2014 Dec; 93(27):e229. PubMed ID: 25501085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.
    Lynch JP; Derhovanessian A; Tazelaar H; Belperio JA
    Semin Respir Crit Care Med; 2018 Aug; 39(4):434-458. PubMed ID: 30404111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late-onset neutropenia after rituximab in ANCA-associated vasculitis.
    Knight A; Sundström Y; Börjesson O; Bruchfeld A; Malmström V; Gunnarsson I
    Scand J Rheumatol; 2016 Oct; 45(5):404-7. PubMed ID: 26948245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
    Cartin-Ceba R; Golbin JM; Keogh KA; Peikert T; Sánchez-Menéndez M; Ytterberg SR; Fervenza FC; Specks U
    Arthritis Rheum; 2012 Nov; 64(11):3770-8. PubMed ID: 22730028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Granulomatosis with polyangiitis with isolated orbital involvement in children: a case report successfully treated with Rituximab and review of literature.
    Riancho-Zarrabeitia L; Peiró Callizo E; Drake-Pérez M; García Montesinos B; Terán N; Martínez-Taboada VM
    Acta Reumatol Port; 2019 Jul; 44(Jul-Sep (3)):258-263. PubMed ID: 31484916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [ANCA-associated vasculitis].
    Krasselt ML; Holle JU
    Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.
    Besada E; Koldingsnes W; Nossent JC
    Rheumatology (Oxford); 2013 Nov; 52(11):2041-7. PubMed ID: 23934313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [IgA nephropathy and granulomatosis with polyangiitis-overlap: a rare coexistence of two glomerular nephropathies with remission after steroids and rituximab].
    Londrino F; Giuliani G; Santostefano M; Baraldi O; Mattiotti M; Mangiulli M; Tatangelo P; Gambardella G; Dominijanni S; Napoli M; La Manna G; Palumbo R
    G Ital Nefrol; 2023 Feb; 40(1):. PubMed ID: 36883919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.
    Sada KE; Nagasaka K; Kaname S; Nango E; Kishibe K; Dobashi H; Hiromura K; Kawakami T; Bando M; Wada T; Amano K; Murakawa Y; Harigai M
    Mod Rheumatol; 2024 Mar; 34(3):559-567. PubMed ID: 37599461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Paradoxical Reaction to Rituximab in Six Granulomatosis with Polyangiitis Patients: How Could it be Explained and Managed?
    Alesaeidi S; Piri SM; Tavakolpour S
    Curr Rheumatol Rev; 2021 Aug; 17(3):327-330. PubMed ID: 33605863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Remission maintenance in ANCA-associated vasculitis: does one size fit all?
    Berti A; Specks U
    Expert Rev Clin Immunol; 2019 Dec; 15(12):1273-1286. PubMed ID: 31762340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.